From “Dr. Joe’s Market Diagnosis”, by Dr. Joe Duarte

Shares of Gilead Sciences (NASDAQ: GILD) may get a bounce as the markets look for way to make money from the swine flu outbreak. But the breakout of a new flu scare brings home a very significant point that goes beyond making money from a potential crisis.

As the swine flu hype kicks into high gear, and President Obama has instructed the Senate Majority to pass health care reform with 51 votes by invoking a complex procedure called reconciliation which blocks filibusters, consider this: fewer physicians, worsening demographics, and decreased reimbursement are coming to a head as the White House increases his focus on health care.

After nearly two decades of managed care, the U.S. health care system is about to lurch into a new degree of uncertainty, and the White House seems to be shocked at what has been obvious to physicians and patients for a few years now. The market has reached the point at which it can no longer bear the stresses put on it. So physicians are opting to opt out.

You must be logged in to view the rest of this article. If you do not have an Investrend Weblogs account, it is free to register.